Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

MARGENZA

MARGETUXIMAB-CMKB

Standard Dose
250MG/10ML(25MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview MARGENZA is listed in Drugs@FDA under application 761150 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MARGETUXIMAB-CMKB Form and strength INJECTABLE;INJECTION - 250MG/10ML(25MG/ML) Sponsor MACROGENICS INC Submission history Latest submission status date: 2025-01-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview MARGENZA is listed in Drugs@FDA under application 761150 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient MARGETUXIMAB-CMKB Form and strength INJECTABLE;INJECTION - 250MG/10ML(25MG/ML) Sponsor MACROGENICS INC Submission history Latest submission status date: 2025-01-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.